A new monoclonal antibody treatment called Kesimpta (ofatumumab) appears to improve on an older drug in pushing multiple sclerosis (MS) into remission, a new tr
In recent years, scientists have found many new treatments that can often help prevent... Drugs that may slow your MS or help nerve damage include: Alemtuzumab (Lemtrada) Beta interferon...
Typically, testing for new MS drugs includes MRI, but also requires more patients and a longer study period— all of which are costly. Because MRI is able to detect MS activity in a very...
Privacy Policy (opens in new window) · Accept all cookies · Manage cookies
Development of an HPLC–ICP–MS method for the determination of platinum species from new anti-tumour drugs Analytical proceedings including analytical communications, v.31 no.10, 1994년...
Topics ; Acorda Therapeutics · Biogen · Chris Viehbacher · J.P. Morgan Healthcare Conference · multiple sclerosis
remitting MS, involving cancer drugs and a stem cell transplant. In the new study, published in the Lancet and funded by Novartis Pharma AG, Craner and colleagues describe how 1,055 adults...
of new patients on its multiple sclerosis evobrutinib drug... The company must now place on hold the initiation of new... That meant recruitment of new participants was stopped. Others in...
the middlemen The Opaque Industry Secretly Inflating Prices for Prescription Drugs Pharmacy benefit managers are driving up drug costs for millions of people, employers and the government.
Alexandra Solal’s 47th year was remarkable by any measure: She climbed Mount Kilimanjaro, ran two half-marathons, completed a half-Ironman, and started a CrossFit gym habit before work with a friend. It was also the year she woke up half paralyzed. Determined not to alarm her son, she commando-crawled to her closet, dressed on the floor, and called her gym buddy to take him to school. “When my friend pulled in, she saw me propping myself up between our two cars and started to cry,” recalls Solal. “That’s when I knew it was bad.” ...